| Combination therapy with bioengineered miR-34a prodrug and doxorubicin synergistically suppresses osteosarcoma growth | |
| Zhao, Yong; Tu, Mei-Juan; Yu, Yi-Feng; Wang, Wei-Peng; Chen, Qiu-Xia; Qiu, Jing-Xin; Yu, Ai-Xi; Yu, Ai-Ming | |
| 刊名 | BIOCHEMICAL PHARMACOLOGY
 |
| 2015 | |
| 卷号 | 98期号:4 |
| 关键词 | Osteosarcoma miR-34a Doxorubicin Chemotherapy Orthotopic tumor |
| ISSN号 | 0006-2952 |
| DOI | 10.1016/j.bcp.2015.10.015 |
| URL标识 | 查看原文 |
| 收录类别 | SCIE |
| 语种 | 英语 |
| 内容类型 | 期刊论文 |
| URI标识 | http://www.corc.org.cn/handle/1471x/4084361 |
| 专题 | 武汉大学 |
| 推荐引用方式 GB/T 7714 | Zhao, Yong,Tu, Mei-Juan,Yu, Yi-Feng,et al. Combination therapy with bioengineered miR-34a prodrug and doxorubicin synergistically suppresses osteosarcoma growth[J]. BIOCHEMICAL PHARMACOLOGY,2015,98(4). |
| APA | Zhao, Yong.,Tu, Mei-Juan.,Yu, Yi-Feng.,Wang, Wei-Peng.,Chen, Qiu-Xia.,...&Yu, Ai-Ming.(2015).Combination therapy with bioengineered miR-34a prodrug and doxorubicin synergistically suppresses osteosarcoma growth.BIOCHEMICAL PHARMACOLOGY,98(4). |
| MLA | Zhao, Yong,et al."Combination therapy with bioengineered miR-34a prodrug and doxorubicin synergistically suppresses osteosarcoma growth".BIOCHEMICAL PHARMACOLOGY 98.4(2015). |
| 个性服务 |
| 查看访问统计 |
| 相关权益政策 |
| 暂无数据 |
| 收藏/分享 |
除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。
修改评论